TGFB1 and polycystic ovary syndrome: PFD administration in healthy animals did not alter TGF-β1 levels (10.83 ± 11.14; P ═ 0.999), while PFD treatment in PCOS rats substantially reduced TGF-β1 expression (48.33 ± 30.11; P < 0.0001).